https://www.nasdaq.com/press-release/dr.-elizabeth-nabel-rejoins-modernas-board-of-directors-2021-03-10

CAMBRIDGE, Mass.(BUSINESS WIRE) Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that Elizabeth (Betsy) Nabel, M.D. has been appointed to the Company’s Board of Directors.

Dr. Nabel was previously a member of Moderna’s Board of Directors from December 2015 to July 2020. She resigned from the Moderna Board in July 2020 to alleviate any potential concern about the conduct or the outcome of the COVID-19 vaccine trial when Brigham and Women’s Hospital was identified by NIH as one of the clinical sites for the Phase 3 trial. Through February 2021, she was President of Brigham Health, which includes Brigham and Women’s Hospital, Brigham and Women’s Faulkner Hospital, and the Brigham and Women’s Physician Organization, a position she held from 2010.

The Board has appointed Dr. Nabel as a Director effective today. She will be included on the slate for re-election as a Class III Director by stockholders at the Company’s upcoming annual meeting on April 28, 2021. Dr. Nabel will serve on the Product Development and Nominating and Corporate Governance Committees of the Board

It's a big club and we aint in it. We pay for the research and they get rich

https://www.msn.com/en-us/news/us/brigham-and-womens-president-to-step-down/ar-BB1cusDX

The president of Brigham and Women’s Hospital, Dr. Elizabeth “Betsy” Nabel, is stepping down after 11 years leading the prestigious nonprofit medical center to pursue opportunities in the for-profit biotech sector.

Nabel said Tuesday that she will depart March 1 and begin working with her husband, Dr. Gary Nabel, who recently left a high-profile job at the drug company Sanofi and launched his own biotech startup.

Her decision to step down from the Brigham, she said, was unrelated to a controversy last year about her previous role as a board member at Moderna, the high-flying biotech company that has developed one of the leading vaccines for COVID-19.

When she leaves the Brigham, Nabel said, she plans initially to focus on her husband’s new venture, which is developing immune therapies for cancer and infectious diseases

https://virtual.keystonesymposia.org/ks/speakers/view/18

Gary Nabel MD, PhD

Sanofi

Gary J. Nabel, Ph.D. is Senior Vice President, Chief Scientific Officer and Deputy to the President for Global R&D at Sanofi. Gary also serves as Chairman of the Strategic Development and Scientific Advisory Council (SDSAC).

Dr. Gary Nabel joined Sanofi in November 2012 from the National Institutes of Health, where he served as Director of the Vaccine Research Center (VRC) of the National Institute of Allergy and Infectious Diseases since 1999. During his tenure at the NIH, Dr. Nabel provided overall direction and scientific leadership of the basic, clinical and translational research activities of the VRC and guided development of novel vaccine strategies against HIV and other emerging and re-emerging infectious diseases, including Ebola/Marburg hemorrhagic fevers, influenza, chikungunya and other viruses.

https://en.wikipedia.org/wiki/Foundation_for_the_National_Institutes_of_Health

The Foundation for the National Institutes of Health (FNIH)] is a not-for-profit, 501(c)(3) charitable organization established by the U.S. Congress in 1990. Located in North Bethesda, MD, the FNIH is an independent organization that raises private-sector funds, and creates and manages alliances with public and private institutions in support of the mission of the National Institutes of Health (NIH).

The FNIH organizes and administers research programs, supports education and training of new researchers, manages educational events and symposia and provides support to patient care activities with the purpose of accelerating biomedical research and strategies against diseases and health concerns in the United States and around the globe.

https://www.fnih.org/our-people/board-of-directors

Chief Executive Officer and Chairman, Karuna Therapeutics

Former Chief Executive Officer, CoGenesys, Inc.

Director Emeritus, Albert & Mary Lasker Foundation

Chief Executive Officer, Ruder Finn Inc.

Chairman, Novalis LifeSciences

Partner, Goldman Sachs & Company; Adjunct Professor, University of Virginia

Chairman, Novartis Institute for Tropical Diseases

President and Co-Founder, Mindstrong Health

Director, Kovler Foundation; Director Emeritus, Sasha Bruce Youthwork, Inc.

Former Chief Medical Officer and Executive Vice President, Pfizer Inc.

Executive Chairman and Founder, Alexandria Real Estate Equities, Inc.

President and Chief Executive Officer, Dame Jillian & Dr. Arthur M. Sackler Foundation for the Arts, Sciences & Humanities

Chairwoman, Edmond J. Safra Philanthropic Foundation

Retired Chairman and Chief Executive Officer, Glaxo Inc.

President and Chief Operating Officer, Beacon Capital Partners

Managing Director and Global Head, BlackRock Private Equity Partners

Vice Chairman of the Executive Committee and Chief Scientific Officer, Johnson & Johnson

https://www.ucsf.edu/news/2021/09/421541/treating-severe-depression-demand-brain-stimulation

UCSF Health physicians have successfully treated a patient with severe depression by tapping into the specific brain circuit involved in depressive brain patterns and resetting them using the equivalent of a pacemaker for the brain.

The study, which appears in the Oct. 4, 2021, issue of Nature Medicine, represents a landmark success in the years-long effort to apply advances in neuroscience to the treatment of psychiatric disorders.

“This study points the way to a new paradigm that is desperately needed in psychiatry,” said Andrew Krystal, PhD, professor of psychiatry and member of the UCSF Weill Institute for Neurosciences. “We’ve developed a precision-medicine approach that has successfully managed our patient’s treatment-resistant depression by identifying and modulating the circuit in her brain that’s uniquely associated with her symptoms.”

Louis Gridley Wu

https://www.rollcall.com/2021/10/04/whistleblower-website-for-capitol-police-officers-launches/

House Administration Committee ranking member Rodney Davis on Monday announced the launch of a webpage for Capitol Police officers to confidentially report problems affecting the department directly to the committee, which has oversight of the police force.

“This committee has a responsibility to the men and women who protect the Capitol to provide oversight of their leadership and part of this is hearing from officers and other personnel when issues arise,” Davis, R-Ill., said in a statement.

“To be honest, I think it’s a way towards transparency,” said Gus Papathanasiou, the head of the department’s union. He later added, “If Rodney Davis wants to do it, I support it.”

Anyone can submit complaints to Capitol Police Inspector General Michael A. Bolton’s office, but the new site gives officers another avenue to raise issues with the committee staff

If Bezos kills Kirk, no-where on this planet will be safe for him

>>14717840

still his fault, lack of proper oversight for monetary gain